Screener
Regenxbio RGNX EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Regenxbio’s reported figures.
Plus components not separately reported this period.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
FAQ
- What is Regenxbio's EBIT?
- Regenxbio (RGNX) reported EBIT of $29.26M in Q2 2026.
- How has Regenxbio's EBIT changed year-over-year?
- Regenxbio's EBIT increased by 146.2% year-over-year, from -$63.28M to $29.26M.
- What is the long-term trend for Regenxbio's EBIT?
- Over 4 years (2021 to 2025), Regenxbio's EBIT has grown at a 0.2% compound annual growth rate (CAGR), from $159.98M to -$161.2M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Regenxbio's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude